A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
A 2-part study to examine safety, tolerability and pharmacokinetics (part 1), and anti-tumour
effects (part 2), of CDP791 combined with carboplatin and paclitaxel.